Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals, Inc, 46730-46731 [2020-16775]
Download as PDF
<![CDATA[
46730
Federal Register / Vol. 85, No. 149 / Monday, August 3, 2020 / Notices
Labs, LLC, Arlington, VA; Velocity
Works LLC, Pittsburgh, PA; Virginia
Tech Applied Research Corporation,
Arlington, VA; Virtualitics, Inc.,
Pasadena, CA; Visible Assets, Inc.,
Stratham, NH; Whitney Strategic
Services LLC, New York, NY; Wind
River Systems, Inc., Alameda, CA; Wind
Talker Innovations, Inc., Fife, WA; and
XTAR, LLC, Ashburn, VA have been
added as parties to this venture.
Also, Affordable Engineering
Services, Inc. (AES), San Diego, CA;
Alamo City Engineering Services Inc.
(ACES), San Antonio, TX; Applied
Research Associates, Inc., Albuquerque,
NM; Centurum Information Technology,
Inc., Marlton, NJ; DUST Identity, Inc.,
Needham, MA; GPS Source, Inc.,
Pueblo, CO; Guidon Technology
Solutions, Inc., Issaquah, WA; HaloTech
Solutions LLC, Columbia, MD; Jasper
Solutions Inc., Huntington Station, NY;
Johns Hopkins University Applied
Physics Laboratory LLC (JHU APL),
Laurel, MD; Louisiana Technology
Group Inc. (LATG), New Orleans, LA;
Netsync Network Solutions, Inc.,
Houston, TX; Parsons Government
Services, Inc., Pasadena, CA; Recogniti
LLP, Hagertown, MD; Rudram
Engineering, Inc., Rockledge, FL;
SafeNet Assured Technologies LLC,
Arbingdon, MD; Sea Machines Robotics
Inc., Boston, MA; Sentient Science
Corporation, Buffalo, NY; Space
Sciences Corporation, Lemitar, NM;
Subsystem Technologies Inc., Arlington,
VA; The Pennsylvania State University,
University Park, PA; The University of
New Orleans, New Orleans, LA; Tkacz
Engineering LLC, Myrtle Beach, SC; and
Warrant Technologies, LLC,
Bloomington, IN, have withdrawn from
this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and IWRP intends
to file additional written notifications
disclosing all changes in membership.
On October 15, 2018, IWRP filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on October 23, 2018 (83 FR 53499).
The last notification was filed with
the Department on April 15, 2020. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on May 5, 2020 (85 FR 26711).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–16700 Filed 7–31–20; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–692]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chemicals, Inc
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 2, 2020.
DATES:
Written comments should be
sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 13, 2020,
American Radiolabeled Chemicals, Inc,
101 Arc Drive
Saint Louis, Missouri 63146–3502,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Metazocine ......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Phenazocine ....................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
VerDate Sep<11>2014
20:39 Jul 31, 2020
Jkt 250001
PO 00000
Frm 00145
Fmt 4703
Sfmt 4703
E:\FR\FM\03AUN1.SGM
03AUN1
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
9300
9330
9333
9652
9715
9743
9801
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
46731
Federal Register / Vol. 85, No. 149 / Monday, August 3, 2020 / Notices
The company plans to manufacture
small quantities of the above-listed
controlled substances as radiolabeled
compounds for biochemical research.
No other activities for these drug codes
are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–16775 Filed 7–31–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–694]
Importer of Controlled Substances
Application: Chattem Chemicals Inc
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 2, 2020. Such
persons may also file a written request
for a hearing on the application on or
before September 2, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
DATES:
Drug code
Methamphetamine.
4-Anilino-Nphenethyl-4piperidine
(ANPP).
Phenylacetone ..
Coca Leaves ....
Opium, raw .......
Poppy Straw
Concentrate.
Tapentadol ........
Schedule
1105
II
8333
II
8501
9040
9600
9670
II
II
II
II
9780
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers. The company
plans to import an intermediate of
Tapentadol (9780), to bulk manufacture
Tapentadol for distribution to its
customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–16773 Filed 7–31–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–690]
Importer of Controlled Substances
Application: Curium US LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 2, 2020. Such
persons may also file a written request
for a hearing on the application on or
before September 2, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 8, 2020, Curium
US LLC, 2703 Wagner Place, Maryland
Heights, Missouri 63043–3421, applied
to be registered as an importer of the
following basic class(es) of a controlled
substance:
DATES:
Controlled substance
Drug code
Ecgonine ..........................................................................................................................................................................
9180
The company plans to import small
quantities of the above-listed controlled
substance to be used in diagnostic
testing.
William T. McDermott,
Assistant Administrator.
BILLING CODE 4410–09–P
Occupational Safety and Health
Administration
Fire Brigades Standard; Extension of
the Office of Management and
Budget’s (OMB) Approval of
Information Collection (Paperwork)
Requirements
Occupational Safety and Health
Administration (OSHA), Labor.
AGENCY:
ACTION:
VerDate Sep<11>2014
23:34 Jul 31, 2020
Jkt 250001
PO 00000
Request for public comments.
Frm 00146
Fmt 4703
Sfmt 4703
Schedule
II
OSHA solicits public
comments concerning the proposal to
extend the Office of Management and
Budget’s (OMB) approval of the
collection of information contained in
the Fire Brigades Standard.
SUMMARY:
DEPARTMENT OF LABOR
[Docket No. OSHA–2011–0009]
[FR Doc. 2020–16774 Filed 7–31–20; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 20, 2020, Chattem
Chemicals Inc., 3801 Saint Elmo
Avenue, Chattanooga, Tennessee
37409–1237, applied to be registered as
an importer of the following basic
class(es) of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug Enforcement Administration
ACTION:
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments must be submitted
(postmarked, sent, or received) by
October 2, 2020.
DATES:
ADDRESSES:
Electronically: You may submit
comments and attachments
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal. Follow the
E:\FR\FM\03AUN1.SGM
03AUN1
]]>Agencies
[Federal Register Volume 85, Number 149 (Monday, August 3, 2020)]
[Notices]
[Pages 46730-46731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16775]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-692]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chemicals, Inc
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 2, 2020.
DATES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 13, 2020, American Radiolabeled Chemicals, Inc,
101 Arc Drive
Saint Louis, Missouri 63146-3502, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid................ 2010 I
Ibogaine................................. 7260 I
Lysergic acid diethylamide............... 7315 I
Tetrahydrocannabinols.................... 7370 I
Dimethyltryptamine....................... 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine.... 7470 I
Dihydromorphine.......................... 9145 I
Heroin................................... 9200 I
Normorphine.............................. 9313 I
Amphetamine.............................. 1100 II
Methamphetamine.......................... 1105 II
Amobarbital.............................. 2125 II
Phencyclidine............................ 7471 II
Phenylacetone............................ 8501 II
Cocaine.................................. 9041 II
Codeine.................................. 9050 II
Dihydrocodeine........................... 9120 II
Oxycodone................................ 9143 II
Hydromorphone............................ 9150 II
Ecgonine................................. 9180 II
Hydrocodone.............................. 9193 II
Meperidine............................... 9230 II
Metazocine............................... 9240 II
Methadone................................ 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine................................. 9300 II
Oripavine................................ 9330 II
Thebaine................................. 9333 II
Oxymorphone.............................. 9652 II
Phenazocine.............................. 9715 II
Carfentanil.............................. 9743 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
[[Page 46731]]
The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical
research. No other activities for these drug codes are authorized for
this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-16775 Filed 7-31-20; 8:45 am]
BILLING CODE 4410-09-P
